Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:LFSTNYSE:OSHNASDAQ:PRVANASDAQ:WGS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLFSTLifeStance Health Group$4.83-2.0%$5.96$4.64▼$8.61$1.88B1.231.63 million shs2.69 million shsOSHOak Street Health$39.00$37.57$13.29▼$39.00$9.52B2.235.76 million shsN/APRVAPrivia Health Group$21.85+0.2%$23.36$16.37▼$26.09$2.66B0.83745,517 shs1.68 million shsWGSGeneDx$67.00+4.0%$75.57$24.91▼$117.75$1.91B1.94792,427 shs607,499 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLFSTLifeStance Health Group0.00%-8.17%-12.02%-28.55%-8.70%OSHOak Street Health0.00%0.00%0.00%0.00%0.00%PRVAPrivia Health Group0.00%-3.53%-4.42%-8.65%+28.68%WGSGeneDx0.00%+3.76%-6.42%-35.07%+143.99%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationLFSTLifeStance Health Group2.3776 of 5 stars3.42.00.00.01.82.50.6OSHOak Street HealthN/AN/AN/AN/AN/AN/AN/AN/APRVAPrivia Health Group4.3305 of 5 stars4.53.00.00.02.93.31.9WGSGeneDx3.6058 of 5 stars3.42.00.00.01.85.01.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceLFSTLifeStance Health Group 2.83Moderate Buy$8.5075.98% UpsideOSHOak Street Health 0.00N/AN/AN/APRVAPrivia Health Group 3.00Buy$27.7727.09% UpsideWGSGeneDx 2.75Moderate Buy$86.7529.48% UpsideCurrent Analyst Ratings BreakdownLatest OSH, PRVA, LFST, and WGS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/28/2025PRVAPrivia Health GroupJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$29.00 ➝ $32.005/27/2025LFSTLifeStance Health GroupUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$8.505/27/2025PRVAPrivia Health GroupBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$23.00 ➝ $24.005/15/2025WGSGeneDxGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$88.005/9/2025WGSGeneDxJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy$80.005/1/2025WGSGeneDxTD SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$135.00 ➝ $110.005/1/2025WGSGeneDxWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$105.00 ➝ $78.004/28/2025PRVAPrivia Health GroupJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$29.00 ➝ $29.004/15/2025PRVAPrivia Health GroupRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$24.00 ➝ $26.004/10/2025PRVAPrivia Health GroupBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$21.00 ➝ $23.004/10/2025PRVAPrivia Health GroupNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$30.00 ➝ $30.00(Data available from 6/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookLFSTLifeStance Health Group$1.25B1.50$0.04 per share121.81$3.78 per share1.28OSHOak Street Health$2.16B4.40N/AN/A($1.10) per share-35.45PRVAPrivia Health Group$1.74B1.53$0.18 per share121.09$5.70 per share3.83WGSGeneDx$305.45M6.26$1.02 per share65.47$8.75 per share7.66Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateLFSTLifeStance Health Group-$57.44M-$0.10N/AN/AN/A-2.78%-2.47%-1.69%8/14/2025 (Estimated)OSHOak Street Health-$509.20M-$2.21N/AN/AN/A-23.57%N/A-25.08%N/APRVAPrivia Health Group$14.39M$0.12182.1080.933.500.87%2.32%1.38%8/14/2025 (Estimated)WGSGeneDx-$52.29M-$1.41N/A32.06N/A-11.69%10.17%5.51%7/29/2025 (Estimated)Latest OSH, PRVA, LFST, and WGS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/30/2025Q1 2025WGSGeneDx$0.11$0.28+$0.17-$0.23$79.90 million$87.12 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthLFSTLifeStance Health GroupN/AN/AN/AN/AN/AOSHOak Street HealthN/AN/AN/AN/AN/APRVAPrivia Health GroupN/AN/AN/AN/AN/AWGSGeneDxN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioLFSTLifeStance Health Group0.191.471.47OSHOak Street HealthN/A1.411.41PRVAPrivia Health GroupN/A1.881.88WGSGeneDx0.203.253.07Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipLFSTLifeStance Health Group85.50%OSHOak Street Health92.04%PRVAPrivia Health Group94.48%WGSGeneDx61.72%Insider OwnershipCompanyInsider OwnershipLFSTLifeStance Health Group6.60%OSHOak Street Health11.55%PRVAPrivia Health Group10.70%WGSGeneDx29.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableLFSTLifeStance Health Group10,218388.88 million363.21 millionOptionableOSHOak Street Health6,000244.00 million215.82 millionNot OptionablePRVAPrivia Health Group1,140121.92 million108.88 millionOptionableWGSGeneDx1,20028.53 million20.09 millionOptionableOSH, PRVA, LFST, and WGS HeadlinesRecent News About These CompaniesGeneDx Holdings Corp. (NASDAQ:WGS) Receives Average Recommendation of "Moderate Buy" from BrokeragesJune 23 at 2:10 AM | marketbeat.comWGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. ...June 22 at 12:13 PM | gurufocus.comWGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your RightsJune 22 at 11:38 AM | globenewswire.comGeneDx (NASDAQ:WGS) Downgraded by Wall Street Zen to "Hold"June 22 at 2:25 AM | americanbankingnews.comGeneDx (NASDAQ:WGS) Cut to Hold at Wall Street ZenJune 21 at 2:54 AM | marketbeat.comGeneDx Holdings: A More Reasonable ValuationJune 20 at 2:58 PM | seekingalpha.comROSEN, A LEADING NATIONAL FIRM, Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGSJune 20 at 1:45 PM | markets.businessinsider.comWGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your RightsJune 19, 2025 | globenewswire.comRosen Law Firm Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGSJune 18, 2025 | prnewswire.comGENEDX ALERT: Bragar Eagel & Squire, P.C. is Investigating GeneDx Holdings Corp. on Behalf of GeneDx Stockholders and Encourages Investors to Contact the FirmJune 17, 2025 | globenewswire.com3 Medical Services Stocks Capitalizing on the Healthcare AI BoomJune 16, 2025 | zacks.comWGS Investors Have Opportunity to Join GeneDx Holdings Corp. Fraud Investigation with the Schall Law FirmJune 16, 2025 | prnewswire.comOversold Conditions For GeneDx Holdings (WGS)June 15, 2025 | nasdaq.comGeneDx, WGS, to rise 3,300% at the open - no, don’t do anything about itJune 14, 2025 | dhakatribune.comAssenagon Asset Management S.A. Lowers Stock Holdings in GeneDx Holdings Corp. (NASDAQ:WGS)June 14, 2025 | marketbeat.comINVESTIGATION ALERT: Edelson Lechtzin LLP is investigating GeneDx Holdings Corp. (NASDAQ: WGS) and Encourages Investors with Substantial Losses to Contact the FirmJune 13, 2025 | prnewswire.com15,937 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Bought by Harbor Capital Advisors Inc.June 13, 2025 | marketbeat.comWGS Investors Have Opportunity to Join GeneDx Holdings Corp. Fraud Investigation with the Schall Law FirmJune 12, 2025 | prnewswire.comRosen Law Firm Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation – WGSJune 12, 2025 | businesswire.comThese 24 Stocks Are Ripe for a Short SqueezeJune 12, 2025 | schaeffersresearch.comGeneDx (NASDAQ:WGS) Trading Down 3.8% - Here's What HappenedJune 12, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeOSH, PRVA, LFST, and WGS Company DescriptionsLifeStance Health Group NASDAQ:LFST$4.83 -0.10 (-2.03%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$4.93 +0.10 (+1.99%) As of 06/20/2025 06:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.Oak Street Health NYSE:OSHOak Street Health, Inc., together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas. The company was founded in 2012 and is headquartered in Chicago, Illinois.Privia Health Group NASDAQ:PRVA$21.85 +0.04 (+0.18%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$21.86 +0.01 (+0.07%) As of 06/20/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.GeneDx NASDAQ:WGS$67.00 +2.57 (+3.99%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$66.50 -0.50 (-0.75%) As of 06/20/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Smith & Wesson Stock Falls on Earnings Miss, Tariff Woes Marvell's New AI Chip Deals Capture Wall Street’s Attention Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer GE Aerospace Turns Engines Into Long-Term Profits 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
